CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis. - Wikidata - awgldk - TriplyDB

CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.

CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.

http://www.wikidata.org/entity/Q34471077

about

NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage.Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Blood-brain barrier damage in vascular dementia.AAV-Nrf2 Promotes Protection and Recovery in Animal Models of Oxidative Stress.Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes.Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy.Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

P2860

Q35408649-9411027B-4890-4B7C-97C7-CEC72884DAA1 Q36052412-7DED0EE6-D1D5-49CD-A913-FA3432644EC1 Q38647755-A438D162-1990-4F20-85C5-A8D15F939D78 Q40311208-53989F77-EF51-4E82-BEE8-6621AE9157BA Q41549542-4213FCE9-D0B4-4745-84CA-A83FD102D58F Q41678966-B3C468D6-9D08-479A-8781-2F39B894E0D0 Q47739408-138495E8-D309-4926-AB39-59A73C963C3D

P2860

CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.

http://www.wikidata.org/entity/Q34471077

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@ast

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@en

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@nl

type

label

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@ast

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@en

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@nl

prefLabel

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@ast

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@en

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis.

@nl

P1433

Q34471077-945FDAE8-E703-44E0-904A-A2BB29DE16D4

P1476

Q34471077-9D21124D-D2C6-488B-A3A7-FC54F324CDA2

P2093

Q34471077-00992076-1B34-4BE4-AC29-7A2C9B188166

Q34471077-0C6FF240-5283-40AA-ADF0-B6A0523A2C96

Q34471077-0CEF423C-2385-4DC5-B339-DF687009F0A5

Q34471077-3545FDC7-3CBA-4E4D-9FB5-6C18534A0ACC

Q34471077-66E20FBD-EE8D-4280-BD2A-4B6F316C68A0

Q34471077-B8D3EE25-008D-4F0F-8F7F-73EB678FE546

Q34471077-E9EB7CEF-4E39-4E37-8988-4B76D138EB8C

P2860

Q34471077-00F79031-584E-4A08-AE1D-E2FFB0F461CB

Q34471077-053B0498-A6DB-4B72-BA66-D8CEF94D6A75

Q34471077-067C2E98-4BE7-432C-9E99-2575CD122806

Q34471077-07AD22E7-9606-4D8D-B73D-BA029A5EDCA1

Q34471077-0AA1819E-B2F5-4BC5-930F-ED8302FA0BD4

Q34471077-0AF88CA7-223E-4CA4-830D-C3263FEF6405

Q34471077-0BACEDF9-901D-4A0E-9254-EFEF6D94075B

Q34471077-11D9914D-18D6-404D-9F31-39D3CAD3A6D8

Q34471077-1635CD03-BA24-4C9A-96E6-7E524932D761

Q34471077-1BD3A3E9-776C-4BEA-A61B-95EB0E7DACC3

P304

Q34471077-F0E5216B-8F96-42BF-8897-637A3144137D

P31

Q34471077-CD3E6739-AAB2-411D-B294-BDF1C7A7A6C3

P356

Q34471077-88BAE0E8-8C6F-460C-A376-19C1510CBCB8

P433

Q34471077-93687255-C081-4267-9CCA-F7F87A15A2CA

P478

Q34471077-6C0E8EDA-B96A-4E98-84EB-6551565AA725

P50

Q34471077-A2A12B46-28E2-4857-BD5D-481F0FE56AD0

P577

Q34471077-F66C08BC-34DA-4635-BDC6-BFBBE6687A17

P5875

Q34471077-13DCFF96-B28B-499E-B822-7DFEDF37AFD7

P698

Q34471077-D67895D9-8719-41AF-900E-D9DA32DB5BD5

P921

Q34471077-243E5B73-1C07-4C7F-9CA4-895B939A3496

Q34471077-4FD03777-9FED-4BCF-9F96-20036A106A6C

P932

Q34471077-84C0A1BA-2C67-4FF3-936B-D34E849D5357

P356

P1433

Antioxidants & Redox Signaling

P1476

CD36 upregulation mediated by ...... Alzheimer's-like pathogenesis

@en

P2093

Chun-Yan Wang

http://www.w3.org/2001/XMLSchema#string

Jian-Hui Cai

http://www.w3.org/2001/XMLSchema#string

Jing-Wei Xie

http://www.w3.org/2001/XMLSchema#string

Li An

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

Xu Wang

http://www.w3.org/2001/XMLSchema#string

Zhan-You Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

Alzheimer's Disease

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Free radicals in the physiological control of cell function

HIF-1: mediator of physiological and pathophysiological responses to hypoxia

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders

Alzheimer's disease is a synaptic failure

Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression

P304

2208-2230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ARS.2014.5845

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261404861

http://www.w3.org/2001/XMLSchema#string

P698

24702189

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4224043

http://www.w3.org/2001/XMLSchema#string